# Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients

> **NCT05081583** · EARLY_PHASE1 · COMPLETED · sponsor: **Washington State University** · enrollment: 22 (actual)

## Conditions studied

- Interaction, Adverse Herb-Drug
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Midazolam Hcl 1Mg/Ml Inj
- **DIETARY_SUPPLEMENT:** Goldenseal (Hydrastis canadensis)

## Key facts

- **NCT ID:** NCT05081583
- **Lead sponsor:** Washington State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2023-01-16
- **Final completion:** 2023-08-31
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05081583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05081583, "Clinical Evaluation of the Pharmacokinetic Goldenseal-Metformin Interaction in Diabetic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05081583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*